Foresite Capital Management Iv, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$237.1M
Q ending 2026-03-31
Prior quarter
$229.7M
Q ending 2025-12-31
Change
+3.2% QoQ · +113.5% YoY
Positions
8
reported holdings
Largest positions
All 8 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Pharvaris N.V. | Shares | $135.0M | 4.8M | |
| Cytokinetics Inc | CYTK | Shares | $33.2M | 503K |
| Eikon Therapeutics, Inc. | EIKN | Shares | $20.6M | 1.9M |
| Lyell Immunopharma, Inc. | LYEL | Shares | $16.1M | 800K |
| Relay Therapeutics, Inc. | RLAY | Shares | $9.9M | 1.0M |
| Xenon Pharmaceuticals Inc. | XENE | Shares | $9.3M | 160K |
| Alector, Inc. | ALEC | Shares | $8.4M | 3.9M |
| Maze Therapeutics, Inc. | MAZE | Shares | $4.7M | 157K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.